confirmed thrombotic cardiovascular

Related by string. * confi rmed . confi rm . confi rms : RANGE VOL KANSAS CONFIRMED . Release Date Confirmed . Buyers Must Confirm / Thrombotic : thrombotic thrombocytopenic purpura TTP . anti thrombotic Lovenox . thrombotic disorders malignant neoplasm / cardio vascular . Cardio Vascular . CardioVascular : cardiovascular disease CVD . diabetes cardiovascular disease * *

Related by context. Frequent words. (Click for all words.) 61 discontinuations due 61 coronary revascularization 61 myocardial infarction stroke 59 myocardial infarctions 58 annualized relapse 57 confidence interval #.#-#.# 57 thromboembolic events 57 treatment emergent adverse 56 composite endpoint 56 placebo controlled trials 55 myocardial infarction MI 55 thrombotic events 55 comorbid conditions 55 virologic failure 55 Arch Intern Med 55 plus prednisone 54 HbA1c levels 54 tiotropium 54 acute coronary 54 thromboembolism 54 events SAEs 54 laboratory abnormalities 54 bivalirudin 54 MIs 53 LVEF 53 myocardial infarction 53 hypomagnesemia 53 TYSABRI treated 53 NYHA class 52 vertebral fracture 52 rehospitalization 52 CYPHER ® Stent 52 ziprasidone 52 Secondary endpoints included 52 QT prolongation 52 confidence interval CI 52 Acute Coronary Syndrome 52 pioglitazone 52 cardiovascular mortality 52 echocardiographic 51 Secondary endpoints 51 endarterectomy 51 left ventricular ejection 51 nonadherence 51 rosuvastatin 51 P = .# 51 venous thrombosis 51 lacosamide 51 % CI #.#-#.# [006] 51 venous thromboembolism 51 LUTS 51 postoperative complications 51 substudy 51 VTE 51 comorbidity 51 nonsignificant 50 spinal cord compression 50 fondaparinux 50 patients receiving ERBITUX 50 Secondary endpoints include 50 comorbidities 50 acute myocardial infarction AMI 50 microalbuminuria 50 vertebral fractures 50 stent implantation 50 valsartan 50 discontinuations 50 renal insufficiency 50 intracerebral hemorrhage 50 stable angina 50 candesartan 50 target lesion revascularization 50 clopidogrel 49 events AEs 49 thrombolytic therapy 49 prespecified 49 renal dysfunction 49 adalimumab 49 enoxaparin 49 DMARD 49 left ventricular dysfunction 49 symptom severity 49 acute myocardial infarction 49 cardiac dysfunction 49 recurrent stroke 49 stent thrombosis 49 Cardiovascular Risk 49 acute coronary syndrome 49 Hospitalizations 49 STEMI patients 49 limiting toxicity 49 Postoperative 49 statin therapy 49 unfractionated heparin 49 cerebrovascular 49 celecoxib 49 secondary endpoint 49 Recurrence 48 carotid endarterectomy 48 RLS symptoms 48 renal function

Back to home page